CollPlant Biotechnologies (CLGN) Return on Sales (2017 - 2025)
Historic Return on Sales for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to 45.55%.
- CollPlant Biotechnologies' Return on Sales rose 10899500.0% to 45.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.07%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 32.06% for FY2024, which is 314500.0% down from last year.
- According to the latest figures from Q3 2025, CollPlant Biotechnologies' Return on Sales is 45.55%, which was up 10899500.0% from 17.75% recorded in Q2 2025.
- In the past 5 years, CollPlant Biotechnologies' Return on Sales ranged from a high of 513.61% in Q3 2021 and a low of 1135.5% during Q3 2024
- In the last 5 years, CollPlant Biotechnologies' Return on Sales had a median value of 4.32% in 2021 and averaged 80.76%.
- As far as peak fluctuations go, CollPlant Biotechnologies' Return on Sales tumbled by -1831831100bps in 2021, and later skyrocketed by 10899500bps in 2025.
- CollPlant Biotechnologies' Return on Sales (Quarter) stood at 621.24% in 2021, then skyrocketed by 87bps to 80.62% in 2022, then soared by 79bps to 16.95% in 2023, then tumbled by -43bps to 24.23% in 2024, then crashed by -88bps to 45.55% in 2025.
- Its Return on Sales stands at 45.55% for Q3 2025, versus 17.75% for Q2 2025 and 0.8% for Q1 2025.